The Effect of EEG Biofeedback on Reducing Postcancer Cognitive Impairment
Jean Alvarez, EdD, Fremonta L. Meyer, David L. Granoff and Allan Lundy
Integr Cancer Ther published online 12 April 2013, DOI: 10.1177/1534735413477192
Efficacy of EEG Biofeedback in Addressing Cognitive Dysfunction in Cancer Survivors
This study examined the efficacy of EEG biofeedback (neurofeedback) in addressing the cognitive sequelae of cancer therapy, commonly known as “chemobrain” or “chemofog.” Approximately fifty percent of breast cancer survivors exhibit cognitive impairment within three weeks of beginning chemotherapy, and half of those have not recovered one year later. Neurofeedback, unlike compensatory strategies currently recommended by the National Cancer Institute and major cancer centers, has the potential to restore cognitive function.
Jean Alvarez, EdD, David L. Granoff, Allan Lundy
Neurofeedback in the News
Study of the Efficacy of Neurofeedback Training on Chemotherapy-Induced Neuropathy Receives 2018 FNAN Award
Each year, the Foundation for Neurofeedback and Applied Neuroscience presents an award – which includes an honorarium of one thousand dollars – to the authors of the publication that, in its consideration, has most significantly advanced the field of neurofeedback during the preceding year.
Neurofeedback Reduces Symptoms of Chemotherapy-induced Peripheral Neuropathy
Neurofeedback, a type of functional brain training, may reduce the symptoms of chemotherapy-induced nerve damage in patients with cancer according to a recent study published in the journal Cancer.
Neurofeedback Improves ‘Chemo Brain’ in Cancer Patients
Neurofeedback, also known as EEG biofeedback or neurotherapy, has the potential to reduce or even reverse the cognitive impairment associated with chemotherapy, according to the results of a pilot study.
Although NeurOptimal® does not directly treat specific conditions, it is a tool that helps alleviate symptoms associated with these and other conditions by improving the overall functioning of the central nervous system.